海王生物(000078.SZ)：上半年净利润3168.17万元 同比下降30.23%

Core Viewpoint - Haiwang Bio (000078.SZ) reported a decline in revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved an operating revenue of 14.312 billion yuan, a year-on-year decrease of 13.95% [1] - The net profit attributable to shareholders was 31.6817 million yuan, down 30.23% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -70.5261 million yuan [1] - Basic earnings per share were 0.0120 yuan [1]